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Skeletal muscle has an innate ability to self-regenerate in response to certain stimuli. In the case 
of trauma, muscle resident stem cells are required to meet the regenerative needs of the tissue. 
These resident stem cells, called satellite cells (SCs), are crucial in the regenerative process 
following injury; understanding the major factors which regulate satellite cell activity can provide 
valuable insight for regenerative medicine. The ability to implement and properly activate 
satellite cells has immense potential in the treatment of conditions including trauma, 
degenerative disorders, and age-related sarcopenia. This review will discuss the current 
understanding of satellite cell-mediated regeneration and the related cellular and molecular 
dynamics involved in regulation. Lastly, current research in this area of regenerative medicine 
and implications for future clinical applications will be explored.   
I. Introduction 
Skeletal muscle (SKM) tissue is one of the most abundant tissues in the human body, 
accounting for ~40% of body mass in the average adult (Zhang, Liang and Shan; Meiliana, 
Mustika Dewi and Wijaya). SKM is crucial for both basic motor functions and quality of life. Its 
most obvious role is providing movement including actions such as locomotion, posture, 
expression, and communication (Meliana et al). Even beyond this ostensible use, skeletal 
muscle tissue serves numerous physiological functions. A major example of this is that SKM is 
the predominant insulin-dependent utilizer of glucose in the human body. While not markedly 
high in relation to other body tissues the metabolic activity of skeletal muscle at rest is significant 
due to the large mass of SKM, and exercise can increase its energy (ATP) demands can 
increase up to nearly 50x from its resting rate (Hargreaves and Spriet). The crucial structural 
and physiological functions of SKM combined with its abundance in the body makes it a vital 
contributor to body homeostasis, including blood chemistry and thermal regulation.  
 The anatomy of skeletal muscle tissue is highly organized, with unique structural 
components that directly relate to its function. The most basic functional unit of an individual 
myofiber within skeletal muscle is a sarcomere which is composed of integrated actin and 
myosin filaments which create the characteristic observable striations characteristic of SKM 
fibers (Figure 1). Upon stimulation by motor neurons at neuromuscular junctions these filaments 
interact and ratchet against each other which shortens the length of the sarcomeres along the 
entire muscle in an ATP-dependent process. The specialized skeletal muscle cells, called 
myofibers or myofibers, are elongated and multinucleate due to the embryonic fusion of many 
precursor cells into a single myofiber. Myofibers can extend many centimeters along the length 

















         Figure 1: Diagram of skeletal muscle organization and relative location of SCs. Created with Biorender.com. 
Myofibers themselves are embedded in an extracellular matrix, a three-dimensional mesh 
scaffolding that supports and organizes tissue components. In SKM, the organization provided 
by the ECM is critical for normal physiology. ECM components integrate skeletal muscles from 
their points of origin to insertion points by integrating into tendons which ultimately integrate into 
bone which SKM pulls upon to provide movement. The ECM is composed of collagenous 
components and various other macromolecules, such as elastin, glycoproteins, and 
proteoglycans, which provide tensile and compressive strength as well as bind and sequester a 
variety of molecular factors. The network of connected ECM meshes that surrounds and 
interweaves between the composite SKM components is generally depicted in three major 
layers: the endomysium, which surrounds individual myofibers, the perimysium, which 
surrounds bundles of myofibers, and the epimysium which envelops the entire muscle (Csapo, 
Gumpenberger & Wessner).  
Being multinucleate, myofibers have a significant amount of plasticity and can undergo 
changes in fiber size and the expression of metabolic characteristics. The elevated ability to 
transcribe its tissue specific proteins gives SKM a great deal of regenerative ability in addition to 
its ability to grow, adapt and regenerate (Collins, Olsen and Zammit). The normal physiology of 
healthy, unstressed skeletal muscle includes constant self-regeneration in which the 
myofilaments and other structural proteins are regularly degraded and synthesized. The balance 
between degradation and muscle protein synthesis (MPS) is what determines if growth 
(hypertrophy), reduction (atrophy), or maintenance of muscle mass occurs. Under normal 
circumstances, skeletal muscle is a relatively stable tissue and regular MPS is achieved via the 
multiple nuclei of the fiber.  
The rate of nuclear turnover is not constant and varies due to a variety of factors 
including muscle activity and fiber type. While there is a marked ability to self-regenerate in 
response to damage, its self-regenerative abilities are finite and MPS requirements can exceed 
the capacity of a myofiber’s existing nuclei. When myofibers are damaged by acute injury or 
substantial overload and require protein synthesis beyond their inherent capacity, resident stem 
cells are activated to augment the regeneration. These cells are called satellite cells (SCs), due 
to their location on the periphery of muscle fibers beneath the basal lamina in the ECM, which is 
often described as the SC “niche.” Activated satellite cells can donate their nuclei to an intact 
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myofiber or can provide new myogenic cells to replace tissue, including entire myofibers, lost 
due to injury. There is ongoing research into how much SC recruitment is involved in normal 
replacement outside of injury, but evidence indicates that nuclear accretion from SCs is a more 
extensive occurrence than previously thought (Bradley, Pulliam and Betta). The dynamics of 
injury-induced SC-mediated regeneration of skeletal muscle will be the primary focus of this 
review, as many of the key events and regulatory mechanisms following acute injury are echoed 
in other models of SKM regeneration and related to dysfunctions such as with age-related 
regenerative decline and chronic muscle diseases (Karalaki et al). 
SCs are the major players in skeletal muscle regeneration (Charge & Rudnicki; Collins et 
al; Forcina, Miano & Pelosi; Fu, Wang & Hu; Järvinen et al). They are multipotent progenitor cells 
with other roles including the formation of skeletal muscle during embryonic development and 
augmentation of muscle protein synthesis in mature myofibers by nuclear accretion. In response 
to significant tissue damage, SCs proliferate, differentiate, and fuse to the site of injury to 
regenerate the affected region of muscle. There are a variety of physiological cues which 
modulate satellite cell activity including inflammatory responses, cell-matrix reactions, and 
numerous molecular signaling factors. This paper will discuss the established model of trauma-
induced SC-mediated myogenesis in adult SKM using corroborated information from literature 
in the fields of physiology, cell biology, and molecular medicine. This review will discuss the 
most prominent and well understood dynamics involved in the regenerative process. 
Understanding the regulation and modulation of SCs in SKM regeneration not only aids the 
understanding of normal physiology but can provide valuable insight for the improving clinical 
treatments and developing future regenerative therapies. Applications of this knowledge have 
immense potential in treatment of acute injury, as well as clinical implications for the treatment 
of dystrophic disorders and age-related sarcopenia. Lastly, this work will identify unknowns and 
areas for future research in this realm of regenerative medicine.  
II. Phases of Satellite Cell Mediated Regeneration 
Recruitment of SCs in tissue regeneration is a complex process involving numerous 
synchronized cellular and molecular events. SCs in their peripheral niche reside in a state of 
quiescence but will re-enter the cell cycle upon activation; once activated, SCs follow a cell fate 
pathway of proliferation and differentiation to ultimately become mature myofibers, either by 
fusing with other nascent myofibers to replace a damaged myofiber or integrating into existing 
damaged myofibers to remodel a functional multinucleated fiber (Collins et al). Proliferation of 
SCs produces myogenic progeny, which may either return to the SC niche to populate the stem 
cell reserve or continue to differentiate into committed myoblasts. These progenitor cells 
terminally differentiate and fuse together and to the injury site to form a structure called a 
myotube which matures into a functional myofiber. Myotubes develop within and fuse to the 
injury site to replace the critically damaged region of a myofiber or can form an entirely new 
myofiber to reconstitute fully functional tissue. This integration into the myofibril repairs the 
damage at the injury site and contributes a new nucleus for future protein synthesis (Forcina et 
al).  
Regeneration of skeletal muscle is described in three major phases: 1) destruction, 2) 
repair, and 3) remodeling (Karalaki et al; Järvinen et al). There is some overlap in the events of 
these phases, however the overall progression of regeneration is best understood with these 
events in sequential context. The destruction phase is initiated by the injury event, where 
damage to myofiber components and ECM catalyzes rapid degeneration at the site. This is 
propagated by various factors released upon ECM disruption and from the damaged myofiber, 
including various growth factors and sarcoplasmic contents. These damage-released factors 
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induce local responses as well as release of additional growth factors and cytokines from non-
muscle tissues in a systemic response when serum levels of damaged muscle derived factors 
(DMDFs). In an acute injury, contraction bands form a “fire door” on the border of the injury 
shortly after the event, which halts the propagation of necrosis from continuing beyond the 
affected site. The injury induces a swift inflammatory reaction and induces the infiltration of 
circulating immunocytes, primarily neutrophils, monocytes, and macrophages, from local 
vasculature to degrade and phagocytize damaged tissue components. Immunocytes at the 
injury site also contribute regulatory cytokines and provoke further escalation of the pro-
inflammatory milieu. These cellular debris remaining after the necrosis and degeneration are 
removed by phagocytic immune cells. Activated SCs migrate to the site of damage and undergo 
asymmetrical division, resulting in a self-renewed SC and a daughter cell which will become a 
committed myoblast. These nascent cells begin to differentiate and proliferate to provide more 
regenerative cells for repair of the damaged myofiber (Järvinen et al).  
Following the destruction and inflammation is the repair phase which involves the 
activation of SCs and regulation of their myogenic progeny by secreted factors. These include 
various growth factors, cytokines and chemokines released upon the local damage, by 
infiltrating immune cells, and by SCs themselves; SC division occurs in response to shifting 
levels of extrinsic factors. Asymmetric division of SCs results in a self-renewal of the SC as well 
as the production of a myogenic daughter cell. This cell differentiates and commits to the 
myofiber cell fate as a myoblast, which will proliferate to expand the supply of myoblasts for 
regeneration of the injury (Järvinen et al; Kuang et al  2007, Chargé & Seale).  
The last phase of regeneration involves terminal differentiation of myoblasts and their 
integration in the site to form functional myofibers. This final phase of remodeling involves the 
fusion of nascent myofibers to each other and to existing myofibers to reform functional tissue in 
the site of injury. The contribution of new nuclei as well as cytoplasmic contents completes the 
regenerative process and regular physiological functions of the muscle can continue (Bradley, 




III. Key Markers in Satellite Cell Activation and Myogenic Cell Fates  
Satellite cells pass through a series of stages between their initial state of quiescence to their 
cell fate as a terminally differentiated and fused myofibers. As somatic cells, each contains the 
same full genome unique to the individual, but the characteristics of each stage of their cell 
cycle is determined by modulating which genes are expressed or inhibited. This progression is 
regulated by various transcription factors and post-transcriptional mechanisms. SCs in each 
stage of their life cycle are identified and characterized by the variable expression of molecular 
markers such as transcription factors, surface proteins, and receptors. 
Proliferation and differentiation are regulated by a handful of key myogenic regulatory 
factors (MRFs), summarized in Table 1., and discussed in greater depth in the next section. The 
first MRFs expressed, myogenic factor 5 (Myf5) and myogenic determination factor (MyoD), 
initiate and propagate differentiation of early myoblasts by the upregulation of secondary MRFs 
myogenin and MRF4. Myogenin and MRF4 induce terminal differentiation of myoblasts into 
myofibers, which express genes for myofiber proteins such as myosin heavy chain (MyHC), 
troponin, and muscle creatine kinase.  
 
Table 1. Summary of Myogenic regulatory factors 
 
Pax7 Characterizes the Quiescent SC 
The transcriptional regulation of satellite cell fates has been well characterized. The paired-box 
transcription factor Pax7 is considered the master regulatory transcription factor of satellite cells 
(Lilija, Zhang and Magli). It is used as the canonical biomarker characterizing quiescent and 
early activated SCs in mature muscle (Segalés, Perdiguero and Muñoz-Cánoves; Schmidt, 
Schüler and Hüttner). While Pax7 is highly expressed and is generally considered the most 
reliable marker, there is recent evidence indicating that the quiescent populations of SCs are 
heterogeneous, and Pax7 is not present in all populations in vivo (Snijders, Nederveen and 
McKay).  
Transcription Factor Present in  Known Activities Main References 
Family 
Pax7 
- Quiescent SCs 
- Activated SCs/Early 
myoblasts 
Maintenance of quiescence and 
promotion of self-renewal.  
Bentzinger et al; 
Buckingham & Relaix;  
Snijders et al; Z. Chao 




- SCs in smooth muscle 
- Embryonic 
myoprogenitor cells 
Regulates migration of muscle 
precursors from somite 
Buckingham & Relaix; 







- SCs & proliferating 
myoblasts 
Induces myoblast differentiation 
Karalaki et al; Snijders 
et al 
MyoD - Differentiating myoblasts 
Myogenic commitment & 
progression towards terminal 
differentiation. 
Karalaki et al; Snijders 
et al 
Myogenin 
- Terminally differentiating 
myoblast 
- Early myofiber 
Terminal differentiation of 
myoblasts 
Bentzinger et al; 
Snijders et al 
MRF4 - Differentiating myofiber 
Terminal differentiation: last MRF 
expressed in maturing myoblasts 
(Snijders, Nederveen 
and McKay; Bentzinger, 
Wange and Dumont) 
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The factor Pax3 is an essential regulator of prenatal muscle development. In adult 
muscle Pax3 can be found expressed in combination with Pax7 in quiescent SCs, and is most 
abundantly expressed in the diaphragm and certain smooth muscles (Buckingham & Relaix; 
Segalés et al). Pax3 is considered a second key regulator upstream of embryonic myogenesis 
and has been identified in rare interstitial myogenic cells in adult tissue, likely descending from 
embryonic cells of the mesodermal somite (Kuang et al 2006). While the post-natal function of 
Pax3+/Pax7- satellite cells in mammals remains to be definitively determined, they have been 
observed to proliferate upon injury and may contribute a small number of myoblasts in post-
injury regeneration, potentially providing some redundancy in the essential function Pax7 
(Chargé and Rudnicki; Buckingham and Relaix).  
 
Asymmetric Division Maintains the Reserve Satellite Cell Population 
A unique ability of SCs, along with some other stem cells, is the ability to undergo asymmetrical 
division. This process produces heterogenous progeny, with one myogenic progenitor cell to 
contribute to regeneration and one “self-renewed” cell which returns to the reserve pool of 
quiescent stem cells for future needs (Karalaki et al; Kuang et al 2007). The myogenic daughter 
cell will upregulate MyoD and continue to commit to the myofiber cell fate, while the other will 
upregulate Pax7, downregulate MyoD, and return to quiescence (Bentzinger et al; Kuang et al 
2007). Asymmetric division is regulated by a variety of factors, including extrinsic interactions 
with the ECM and PAR complex proteins (Feige, Brun and Ritso). The PAR complex has been 
identified through extensive research in Drosophila melanogaster and Caenorhabditis elegans, 
and remains an active area of study in other metazoan species in the context of asymmetric 
division of stem cells (Dewey, Taylor and Johnston). Ultimately, the asymmetric orientation in a 
dividing cell and subsequent asymmetric inheritance of PAR components contribute to 
differentiation of daughter cells by linking cell fate determinants with mitotic spindle orientation. 
The cytoplasmic polarity creates the heterogenous daughter cells by contributing different 
transcriptional factors, receptors and ligands to the daughter cells. Interactions with the 
extracellular matrix components are significantly involved in the regulation of SC polarity via 
PAR complex proteins. This asymmetry contrasts with pathways which lead to more equal 
inheritance among daughter cells, including the planar cell polarity pathway (Dewey et al).   
Specific to the PAR-regulated asymmetrical division of activated SCs, the myogenic 
daughter cell has activation of mitogen-activated protein kinases (MAPKs) related to MyoD and 
Myf5 upregulation for proliferation and differentiation (Dewey et al). Conversely, the cell primed 
for self-renewal remains Pax7+ and MyoD-, regulated through extracellular receptor kinase (ERK) 
signaling inhibitor Sprouty1 (Spry1) (Fu, Wang & Hu). Spry1 has been shown to be crucial for 
maintenance of quiescence and for self-renewal following SC activation. It is robustly expressed 
in quiescent SCs and downregulated in proliferative myoblasts (Shea, Xiang and LaPorta). The 
Spry1+ self-renewing daughter cell expresses higher levels of Pax7 and other regulatory factors, 
and returns to the quiescent niche (Bentzinger, Wange and Dumont; Fu, Wang and Hu; Shea, 
Xiang and LaPorta)   
 
Myoblast commitment and cell cycle progression occurs with upregulation of Myogenic 
Regulatory Factors 
Along with Pax7, the MRFs Myf5, MyoD, Myogenin and MRF4 are key biomarkers and 
modulators of myogenic differentiation (Relaix, Bencze and Borok; Schmidt, Schüler and 
Hüttner). The activation of SCs is induced at least in part downstream responses to the 
disruption of the SC niche. Activating stimuli include expression of activation protein-1 (AP-1) 
7 
 
members, MAPKs, and members of the activating transcription factor (ATF) family (Shaulian and 
Karin). The myogenic progeny of activated SCs show rapid upregulation of MyoD and/or Myf5 
following activation, which induce proliferation (Chargé and Rudnicki). At this point, the 
proliferative MyoD+ and/or Myf5+ myogenic cells are termed myoblasts. MyoD or Myf5 
expression is an absolute requirement for differentiation of myoblasts in regeneration, which has 
been demonstrated in studies with double knockout (MyoD-/Myf5-) cells failing to express 
myogenin or myosin heavy chain (MyHC) and instead adopting fibroblast-like morphology 
(Yamamoto, Legendre and Biswas). Myoblasts with MyoD and/or Myf5 will continue to 
differentiate and upregulate myogenin, then MRF4, and commit to terminal differentiation to 
become committed myofibers. These nascent myofibers will fuse together into a myotube via 
expression of surface adhesion molecules then integrate into existing tissue infrastructure of 
adjacent myofibrils or ECM components. Ultimately these cells will express MyHC, and other 
characteristic proteins of mature myofibers and continue MPS as part of the functional mature 
muscle. (Karalaki, Fili and Philippou; Yamamoto, Legendre and Biswas).  
 
Epigenetic considerations 
There is a significant amount of recent and ongoing research into satellite cell modulation by 
epigenetic mechanisms beyond the normal regulatory epigenetic events that occur with transit 
through stages of differentiation (Massenet, Gardner & Chazaud). Causes of epigenetic changes 
are numerous and often difficult to predict but are known to occur by environmental factors or 
physiological variations which act directly or indirectly on one’s genomic expressions. Genomic 
expression is altered by the upregulation or silencing of gene expression through interference 
with transcription factors, chromatin remodeling, or indirect alterations to post-translational 
control mechanisms. Specific to satellite cells, a large amount of literature exists discussing the 
effects of epigenetic influences on their differentiation and proliferation and how these would 
affect regeneration. While chromatin remodeling and temporal changes in transcription factor 
activity is a part of normal cell fate transit, such as in the modulation of regulatory proteins and 
heterochromatic reorganization involved with myogenic differentiation downstream of MRFs 
(Agarwal, Hardt and Brero; Massenet et al; Z. Chao, X.-L. Zheng and R.-P. Sun; Gurung & 
Parnaik). Epigenetic changes which may alter normal cell fates and can hinder satellite cell 
recruitment or reduce the capacity to self-renew (Dacwag, Bedford and Sif; Parker). These 
factors are important to recognize in considering individual variations in satellite cell activity, as 
well as age-related sarcopenia and dystrophic pathologies. Specific epigenetic mechanisms and 
variances in the normal regulatory pathways are an expanding field of research that may provide 






Top: Phases of SC differentiation during regeneration with associated marker and protein expressions. Actively expressed factors 
in green, factors downregulated (absent or otherwise physiologically insignificant levels) in red.  
Bottom: Temporal expression of MRFs from of SC activation to myoblast differentiation, fusion, and in resulting myofiber. 
Image created using Biorender. 
 
IV. Inflammation & Immune cell dynamics 
Acute perturbations of muscle tissue initiate a series of complex interactions with the 
immune system which contribute to the regulation of regeneration. The immune response in 
regeneration of mature muscle is a major difference in comparison to myogenesis during 
development, and the cytokines released contribute to the modulation of transcriptional 
activities of SCs and the subsequent myoprogenitor cells. The inflammatory phase is initially 
characterized by neutrophil invasion, followed by a sequential increase in other immunocytes 
including macrophages and monocytes (Filippin, Cuevas and Lima, The role of nitric oxide 
during healing of trauma to the skeletal muscle). Proinflammatory cytokines including 
interleukin-1 (IL-1) and tumor necrosis factor ɑ (TNF-ɑ) released in inflammatory responses by 
Th1 cells, neutrophils, and M1 macrophages propagate the tissue damage, which induce further 
release of NO (Filppin, Cuevas and Lima; Karalaki, Fili and Philippou; Tidball & Villalta). One way 
that proinflammatory cytokines contribute to tissue damage is by releasing reactive oxygen 
species (ROS) via activation of NADPH oxidase, which can damage lipids, proteins, and nucleic 
acids in macromolecular structures (Filippin, Cuevas and Lima). Major proinflammatory 
cytokines released by myeloid immunocytes in the early response include tumor necrosis factor 
(TNF-ɑ) and interleukin-1 (IL-1). TNF-ɑ is a known modulator of chemotaxis and has specifically 
been observed to inhibit terminal differentiation and muscle cell fusion while stimulating 
proliferation of early-stage myoblasts (Tidball). 
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The initial event upon injury to muscle tissue is a rapid degeneration of the damaged 
myofibers, which morphologically resembles necrosis (Ciciliot and Schiaffino; Chargé and 
Rudnicki). Serum levels of muscle proteins (e.g., creatine kinase, skeletal troponin, MHC) are 
subsequently elevated, inducing the complement cascade and the chemotactic recruitment of 
inflammatory cells to the site (Karalaki, Fili and Philippou, Muscle Regeneration: Cellular and 
Molecular Events; Ciciliot and Schiaffino). The role of immune cells is crucial to the first stages of 
regeneration, and the dynamics between different types promotes different phases of 
regeneration and SC cell fates. Initially following injury, resident mast cells and macrophages 
sense chemotactic molecules released by local damage, and secrete pro-inflammatory 
cytokines, such as IL-6, TNF-ɑ, and histamines which promote activation and proliferation of SCs 
and recruit other immunocytes to the site (Bentzinger, Wange and Dumont). 
The first inflammatory cells to infiltrate are phagocytes, predominantly neutrophils and 
macrophages, which enter from the blood stream and phagocytize necrotized components and 
debris (Tidball & Villalta). Neutrophils attracted by TNF-ɑ and other components released by 
damaged tissue secrete chemokines which recruit supplemental immunocytes to the area 
(Bentzinger, Wange and Dumont) (Yang, Zhang and Yang). Cytokine secretions (e.g. IL-1 and 
IL-6) from neutrophils and resident macrophages stimulate the extravasation of monocytes to 
the injury site and their subsequent differentiation into additional macrophages, which are 
critical players in temporal and spatial events in the regenerative response (Howard, Pasiakos 
and Blesso; Lu, Huang and Saederup). Macrophages are polarized as M1 and M2 phenotypes, 
which can be considered pro- and anti- inflammatory, respectively. The M1 phenotype peaks 
initially within 1-2 days post-injury and contributes to the acute pro-inflammatory response with 
the secretion of cytokines including TNF-ɑ, IL-1β, and IFN-γ, and ROS. These factors facilitate 
the removal of cellular debris and stimulate proliferation of myoblasts while suppressing 
differentiation in the early phases following injury.  
As regenerative responses progress, M1 macrophages convert to the anti-inflammatory 
M2 phenotype which peaks by 3 days post injury to become the predominant phenotype at the 
injury site. The conversion to M2 macrophage dominance at the site shifts to an anti-
inflammatory state which stimulates the differentiation of the pool of nascent myoblasts towards 
terminal differentiation and integration (Howard et al; Karalaki et al; Lu et al). M2 cells express 
high levels of anti-inflammatory molecules to inhibit further damage and growth factors to 
continue the regenerative process (Bentzinger et al; Howard et al).  The transient shift in bias 
from a local pro-inflammatory to anti-inflammatory milieu by macrophage skewing is crucial for 
facilitating the regenerative response. Diminished, excessive, or chronically extended 
inflammatory responses attenuates proper myoblast recruitment and proliferation and is 
considered a major factor in age or disease-related impairment of SKM regeneration (Howard et 
al). 
 
V. The Satellite Cell Niche and Interactions with the Extracellular Matrix 
The extracellular matrix (ECM) is the acellular component present in every tissue, which 
provides physical infrastructure for the macro and micro constituents of the tissue as well as 
workspace for crucial physiological functions and signaling to occur. Without the ECM to 
support and connect the many cells that make up a tissue, cell-cell communication would be 
impossible, and processes of cell differentiation, tissue morphogenesis, and homeostasis could 
not occur. The histological environment that a cell resides in is commonly called its niche and 
includes both the structural ECM components as well as soluble materials in the surrounding 
interstitial space (Gillies and Lieber). In SKM, the ECM strongly contributes to muscle’s normal 
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function and its ability to adapt and composes the biological reservoir for quiescent SCs. The 
importance of SC-niche interactions is indisputable, as satellite cells removed from their niche 
readily lose their stem cell characteristics (Bentzinger, Wang and von Maltzahn).  
SCs quiescence is actively maintained and regulated through extrinsic interactions with 
acellular structures and soluble components. The integrity of the niche along with spatial and 
temporal cues based on factors such as composition, porosity and stiffness directly influence 
SC activity through focal adhesions. Similarly, the activation of SCs involves interactions with 
soluble growth factors from the niche along with circulatory supply of immunocytes and their 
secreted factors. After ECM disruption, the release of ECM-bound growth factors and 
downstream signals are detected, along with pro- and anti-inflammatory cytokines from 
infiltrating immunocytes. The remodeling phase of the regenerative process involves reforming 
the ECM elements for support of the regenerated tissue and accessory structures and return to 
physiological homeostasis. 
As previously stated, quiescent SCs are peripherally located and surround myofibers. 
Specifically, they lie between the sarcolemma and the surrounding ECM, within a cleft beneath 
the basement membrane (BM), which forms a membrane-like sheath around myofibers. This 
subdivision of the BM is technically distinct from the endomysium, which generally surrounds 
myofibers, however for greater context it should be recognized that the two are intimately 
connected. The BM has two major layers: the basal lamina (BL) and the reticular lamina (RL) 
(Rayaggiro, Ranaldi and Raven; Thomas et al). Of these two layers, quiescent SCs are in the 
most direct contact with components of the BL. The BL is primarily composed of collagen type 
IV and laminin-2 (ɑ2, β1, and γ1 chains) assembled in cross-linked networks which are 
connected by glycoproteins and proteoglycans. The BL integrates with the RL via proteoglycan 
connections between collagen in the BL and the RL. Resident fibroblasts in the BM are the 
major source of ECM components in skeletal muscle, contributing collagens, laminin and 
glycoproteins (Thomas et al). On the myofiber-facing side of the SC surface cadherins and 
glycoproteins interact with components of the sarcolemma (Nissar, Martowirogo and Gilbert). 
SCs in the quiescent niche directly interact with extracellular components via surface integrins, 
primarily isoforms ɑ7 and β1, which form a receptor complex that binds laminin-2 in the BL 
(Thomas, Engler and Meyer). The physical stability of the SC in its niche is strengthened by BL 
binding to actin in the cytoskeleton of the muscle fiber by dystrophin complexes.  
SC focal adhesions include cell adhesion molecules (CAMs) and surface attachment 
proteins. (e.g., M-cadherin). These surface molecules provide means of signal reception, 
including cell-cell interaction and cell-matrix interactions. NCAM (neural cell adhesion molecule), 
for example, is upregulated as myoblasts differentiate and is a likely facilitator of myoblast 
recognition and fusion for the formation of the myotube (Snijders et al). Connection of quiescent 
SCs and ECM-associated intracellular structures create force-sensing signals that relay the 
status of the tissue in regard to ECM integrity (Holle and Engler; Thomas et al). These external 
sensors are unevenly distributed on the quiescent SC surface, correlating with structural 
arrangement of the niche and orientation of extracellular cues.  
A major role of the SC niche in regulating its physiology is the establishment of apical-
basal polarity of quiescent cells (Feige et al). The basal and apical cell surfaces of quiescent SCs 
have different expressions of adhesion proteins. The basal surface has high levels of 
dystroglycan and integrins-ɑ7 and -1β. On the apical surface adjacent to the sarcolemma, M-
cadherin and NCAM are predominantly expressed. The polarized niche is the fundamental basis 
for establishing intracellular polarity, which is essential for asymmetric division involving the 
orientation of the mitotic spindle for the organization of PAR complex proteins and sequestration 
of cell fate determinants. Restriction of the PAR complex and PAR complex proteins to cell poles 
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is influenced by the binary localization of adhesion factors Significantly, adhesion to the 
dystroglycan complex which links to the BM of the immediate niche and establishes the basal 
pole of a dividing cell to determine the self-renewing daughter cell. Loss of contact to apical 
sarcolemma components or with basal dystrophin components, such as in cultured SCs in vivo 
results in loss or reversal of internal polar orientation (Feige et al).  
The extracellular orientation provided by cell surface adhesion molecules also cues 
physiological changes for the stimulation of SC activation. A significant cue of structrual 
disruption is SC binding to the glycoprotein fibronectin, which is primarily expressed in the RL 
and generally absent in the BL. The binding of fibronetin to the SC co-receptor complex is a 
contributory factor which stimulates proliferation. Notably, SCs themselves express the 
fibronectin and transiently upregulate the expression upon activation in a manner of autologous 
feedback which further increases proliferation (Bentzinger et al)  
In addition to providing structural integrity and spatial cues, ECM components include 
various soluble factors integrated within the network of macromolecules. Negatively charged 
proteoglycans (e.g., perlecan, decorin, small leucine rich proteoglycans (SLRPs)) distributed 
throughout the BM can bind and sequester a variety of growth factors and signaling molecules, 
which implements the role of the ECM as a source for local and systemic signal conduction 
(Thomas et al). Some of these factors are latent in the quiescent niche and are released upon 
perturbation to the tissue, either directly or through downstream activation.   
In the context of acute injury with damage to the muscle fiber and sarcolemma, rapid 
dissolution of the sarcolemma occurs and further increases the permeability of the damaged 
myofiber. The major enzymes responsible for the catalysis of ECM degradation are matrix 
metalloproteinases (MMPs), which directly target the collagen IV and laminin of the BL and can 
indirectly activate proinflammatory cytokines and release pro-inflammatory factors bound to 
ECM (Quiding-Järbrink et al). MMPs are canonically produced by many cell types, particularly 
activated macrophages, lymphocytes and granulocytes. Recent in vivo data suggests that 
activated SCs express MMP isotypes which facilitate their migration from the quiescent niche to 
the site of injury and further increase the release of ECM bound factors (Thomas et al). 
ECM disruption and increased permeability following MMP activity results in increased 
serum levels of muscle-specific components usually sequestered within the cytoplasm of a 
muscle fiber (Tidball & Villalta). These damaged myofiber-derived factors (DMDFs) such as 
muscle-specific proteins, enzymes, and mRNAs act as stimulatory cues for a variety of steps in 
the regenerative process. Several DMDFs have been implicated in the activation of SKM SCs, 
primarily metabolic enzymes and structural proteins. There is strong indication that the presence 
of SKM-abundant proteins and/or SKM-specific isoforms of metabolic enzymes into interstitial 
space acts as a physiological cue for regenerative cells, however the exact mechanisms are yet 
to be elucidated. Certain DMDFs, including adenylate kinase, creatine kinase, and triose 
phosphate isomerase, have shown significant effect on SC activation both ex vivo and in vivo. It 
has been proposed that these DMDFs also recruit inflammatory cells in the early phases of 
regeneration (Tsuchiya et al). While the mechanisms of activation are unclear, the data 
indicating direct induction by these DMDFs is statistically significant and warrants further 
research into their functional significance in the context of injury and degenerative disorders.  
 
VI. Soluble Factors 
Various soluble factors, including growth factors and cytokines, serve as molecular signals 
which provide distinct cues to their target cell to induce or inhibit various actions. The following 
factors discussed in detail are the most well researched and have extensive evidence 
supporting their roles in SKM regeneration and SC activity. The identification of other regulatory 
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factors in SKM regeneration and SC activity is an ongoing area of research, and includes some 
intriguing evidence for the influence of molecules such as bone morphogenic protein (BMF) 
(Stantzou, Schirwis and Swist) and hypoxia signaling factors (Xie, Yin and Nichenko), as well as 
factors involved in angiogenesis, neurotrophy, and neurogenesis which relate to development 
and regeneration of muscle tissue as a whole and its surrounding structures that may also 
influence myogenic activity (Ho, Chiang and Chuang) (Sugg, Korn and Sarver) (Gerli, Moyle and 
Benedetti) (Saini, Faroni and Reid) 
Insulin-Like Growth Factor 1 (IGF-1) 
The family of IGFs has a multitude of functions in mammalian cells. In skeletal muscle, IGF-1 is 
by far the most well-known and researched IGF, and it is clear the growth hormone-IGF axis 
plays a major role in muscle growth and development. IGF-1 is a circulating factor produced and 
released both by the liver as well as by local paracrine action of muscle cells and M2 
macrophages (Lu et al; Mourkioti and Rosenthal). IGF-1 is known to induce muscle hypertrophy 
by promoting muscle protein synthesis and increasing myofiber size, as well as facilitating 
energy availability by increasing glucose uptake and activating enzymes for anaerobic glycolysis 
(Karalaki, Fili and Philippou).  
In the context of muscle regeneration, IGF-1 positively stimulates most of the steps in 
myoblast proliferation and differentiation by upregulating the expression of intracellular 
mediators, such as mTORC1 and cyclin-D, and by inducing the expression of myogenin (Chargé 
and Rudnicki; Karalaki, Fili and Philippou; Mourkioti and Rosenthal). Likely through the combined 
interactions with other environmental and intracellular factors, IGF-1 induces different activity 
over the duration of the regenerative processes. In early stages, IGF-1 released from damaged 
muscle reduces myogenic factors and induces SC proliferation. Following proliferation IGF-1 
expression is correlated with increased myogenin expression for differentiation of the nascent 
cells, and downregulation of cell cycle markers later. This shift is due to de-escalation of local 
inflammatory response by immunocyte release of anti-inflammatory cytokines after phagocytosis 
of damaged tissue components and cellular debris (Karalaki, Fili and Philippou).  
The various actions of IGF-1 can be at least in part explained by the expression of its 
different isoforms and binding proteins (Mourkioti and Rosenthal). Multiple IGF-1 isoforms have 
been identified in skeletal muscle: IGF-1Ea, IGF-1Eb, and IGF-1Ec (Duan et al; Karalaki et al; 
Mourkioti and Rosenthal). These various isoforms are transiently related to different phases in 
regeneration and/or hypertrophy of SKM, and different binding proteins specific to each isotype 
are expressed along the process of differentiation. For example, IGF-1Ec, commonly known as 
mechano-growth factor, is released in response to muscle loading/training. IGF-1Ea is correlated 
to Mrf4 expression and increased muscle protein synthesis demands in late-phase regeneration. 
Ligand binding of IGF-binding proteins induces autophosphorylation and activates multiple 
signal transduction cascades. The notable induced pathways in skeletal muscle differentiation 
include P13k-Akt, Akt-mTOR, p38 MAPK, and Erk1/2 MAPK (Duan, Ren and Gaol Mourkioti and 
Rosenthal).  
 
Hepatocyte Growth Factor (HGF) 
HGF is a multifunctional cytokine that was first described as a mitogen in mature hepatocytes. It 
is produced in the spleen and liver cells and upregulated in response to muscle damage, as 
detected by elevated serum levels of SKM-specific components (Chazaud; Hawke and Garry; 
(Yamada, Tatsumi and Keitaro). HGF is one of the factors bound within the ECM of skeletal 
muscle, so is one of the first cues involved in SC activation and its release is proportional to the 
degree of muscle injury (Chazaud; Filippiin et al). In addition to its release from non-muscle 
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tissues in systemic response, HGF may additionally be brought to the site by granulocytes 
during the inflammatory response (Snijders, Nederveen and McKay). Further, HGF release from 
stretching stimulus has been found to be dependent on local NO production, either by a paired 
release from the ECM or by events downstream of NO-mediated ECM degradation. Both in vitro 
and in vivo, HGF transcription and signaling have been correlated with activation of quiescent 
SCs and NO synthesis, propagating the phases of regeneration (Chazaud; Filippin et al 2011).  
HGF acts as a potent chemotactic factor involved in activating and selectively promoting 
satellite cell proliferation while inhibiting myoblast differentiation through the transcriptional 
silencing of MyoD and myogenin. It is believed to promote the exit from quiescence through the 
activation of p38 MAPK and P13K (phosphatidylinositol 3-kinase) signaling pathways, and the 
downregulation of caveolin-1 protein expression which has SC activating effects downstream 
(Karalaki, Fili and Philippou). Recent research has shown that HGF at low doses potentiates the 
ECM-mediated migration of myoblasts (González, de Mello and Butler-Browne). The 
concentration-dependent feedback of HGF correlates positively with SC activation and 
proliferation until a threshold is reached, then there is a negative feedback effect associated with 
the expression of myostatin, an inhibitor of SC activation and myoblast proliferation. This is 
thought to be a function for the halting of SC activation after the initial period of SC expansion to 
allow progression of the regenerative progress and to reestablish the quiescent pool of reserve 
SCs (Yamada et al). It has been postulated that HGF may stimulate the migration of SCs and 
myoblasts to the site of injury from surrounding regions, perhaps through the activation of the 
ERK pathway (Karalaki 2009). 
 
Fibroblast Growth Factors (FGFs) 
There are multiple different isoforms of FGFs currently identified in the body. While numerous 
paracrine FGFs are broadly expressed, FGF-6 is restricted to skeletal muscle (Hawke and 
Garry). The mRNA for four of the isoforms (FGF-1, -2, -4, and -6) are reliably detected in SCs 
and their expression has been shown to stimulate proliferation of cultured SCs (Hawke and 
Garry; Husman et al; Karalaki et al; Pawlikowski et al). FGFs in SKM are bound to 
proteohepharan sulfates in the ECM and released within the period of inflammation after tissue 
disruption (Husman et al). There is evidence that FGF the main action of FGFs is stimulation of 
myoblast proliferation, likely involved with regulation of MyoD expression. There is some data 
suggesting that FGF expression encourages proliferation through indirect routes involving the 
upregulation of certain IGF isoforms which have inhibitory effects on myoblast differentiation 
(Karalaki et al).  
FGF-6 is produced by myofibers and is transiently upregulated in response to tissue 
disruption and inflammation (Armand, Laziz and Chanoine)Pawlikowski et al). FGF-6 expression 
is particularly elevated after SKM injury and has been observed to induce morphological 
changes to the ECM and alter SC adhesion. (Karalaki et al). Additionally, absence of FGF-6 has 
been shown to increase fibrosis and enable degradation of nascent myotubes after injury. 
Besides what is embedded in the ECM, FGF-2 is produced locally by myofibers and fibroblasts, 
and in an autocrine fashion by SCs themselves. FGF-2 is often reported as a SC mitogen, and its 
expression is correlated with the repression of myogenesis while SC proliferation occurs. 
Responsiveness to FGF-2 has also been correlated with SC capacity for self-renewal and cell 
fate progression in differentiating myoblasts (Bernet, Doles and Hall; Pawlikowski et al).  
Outside the effects on SC activity, FGFs likely contribute to the regenerative process in 
tissue-specific ways involving the development of supportive components, the most significant 
being vascular structures and peripheral nerves. Several members of the FGF family are known 
agents in neuronal genesis and maintenance. Along with nerve growth factor, FGFs are more 
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prominently secreted by SCs and by neurons under physiological conditions; these GFs are 
indicated in maintaining the necessary microenvironment after trauma to facilitate axonal 
sprouting and elongation. FGF-2 in particular is a known neuroprotective agent closely involved 
with enhancement of neurite outgrowth and axonal regeneration. The neuroprotective qualities 
of FGFs is known to interact with various pathways including the MAPK/ERK signaling cascade 
(Cui). Lastly to note, regarding angiogenesis, FGF-2 and FGF-6 are soundly corroborated as 
potent angiogenic factors which contribute to neovascularization after injury (Murakami and 
Simons). 
 
Transforming Growth Factor β (TGFβ) 
TGFβ is a multifunctional cytokine superfamily with diverse functions. In the context of SKM 
regeneration, subtypes of TGFβ (-1, -2, and -3) have similar and redundant activities in vivo in 
the context of SKM injury (Husmann et al) TGFβ is a latent complex in a homeostatic state, 
stored in the quiescent ECM and not detectable in SKM until injury. It is released upon injury 
and degradation and is also one of the cytokines released by degranulating platelets at the injury 
site. In the context of injured muscle, TGFβ generally inhibits myoblast proliferation and 
differentiation, but seems to not attenuate IGF-1 or FGF-mediated stimulation (Xu et al; Hawke 
and Garry). There is a positive autoregulatory effect wherein the presence of unbound TGFβ 
stimulates further release from local cells; (Filippin et al). Outside of the effects on SCs and 
myoblasts, TGF functions as a chemoattractant for macrophages and other leukocytes, and 
induces the release of FGF, TNF, and IL-1 from monocytes, enhancing the inflammatory 
response. TGFβ has also been observed to stimulate the production of platelet-derived growth 
factor, which would contribute to consequential stimulation of angiogenesis in the nascent 
tissue. TGFβ mediates ECM remodeling by downstream inhibition of MMPs, attracting fibroblasts 
and stimulating the synthesis and deposition of ECM proteins. This is relevant both in a normal 
regenerative context and in the progression of fibrosis, a consequence of excessive ECM 
deposition by fibroblasts which high TGFβ could induce. Recent evidence has also led to some 
postulation that TGFβ may increase collagen deposition indirectly by inducing alternate 
differentiation of myogenic cells into fibroblasts (Filippin, Cuevas and Lima).  
 
Nitrous Oxide (NO) 
While many of the mechanisms are unclear, it is apparent that NO is involved in stimulating SKM 
regeneration and mediating fibrosis (Filippin, Cuevas and Lima, The role of nitric oxide during 
healing of trauma to the skeletal muscle). In muscle injury, NO release occurs as a result of 
acute matrix stretching stimulus or other more severe mechanical perturbations including shear 
stress and degradation, such as by MMPs (Filippin, Cuevas and Lima, Nitric oxide regulates the 
repair of injured skeletal muscle). The mechanisms of SC activation are likely related to effects 
on HGF release, inflammation and MMP activation. NO acts as a pro-inflammatory factor by 
activating cyclooxygenases and increasing prostaglandin production, which promotes 
inflammation and proteolysis of tissue structures.  
Blocking early NO expression has been shown to increase collagen deposition and 
decrease SC activation and myoblast proliferation. NO inhibition also shows significant reduction 
in the acute inflammatory reaction following trauma, including reduced edema and immunocyte 
infiltration. This is likely contributed to by the vasodilatory effects of NO increasing circulation 
and perfusion in the injury site and allowing mobility of soluble factors and infiltration of non-
resident cells. The pro-inflammatory oxidative stress induced by NO production in the early 
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phases of injury have been observed to skew trauma response away from production of fibrotic 
scar tissue and towards functional regeneration (Filippin et al 2011).  
 
Interleukin 1 (IL-1)  
IL-1 is a family of pro-inflammatory cytokines considered master regulators of innate immune 
responses including inflammation (Kaneko, Kurata and Yamamoto). There are two forms of IL-1, 
IL-1ɑ and IL-1β are structurally similar, considered ultimately homologous in terms of biological 
functions, and expressed in a wide range of tissue and cell types. IL-1ɑ is a characteristic 
danger signal that induces inflammation upon release from necrotic cells. The IL-1ɑ precursor 
triggers expression of IL-1 receptors on resident macrophages, which in turn produce IL-1β 
along with other chemokines related to post-necrotic inflammation. IL-1β is most prominent in 
acute inflammation, secreted by pro-inflammatory monocytes and M1 macrophages. As with  
many other pro-inflammatory factors, IL-1β has an inhibitory effect on proliferation and 
suppresses mitogenic activity in myoblasts during the initial pro-inflammatory response. 
However, some data indicates that IL-1β has some inductive effect in the activation of MRFs at 
the commitment stage and positive proliferative effects through combined engagement with IL-6 
at certain IL-6 receptors (Alvarez, DeOcesano-Pereira and Teixeira). 
 
Interleukin 6 (IL-6) 
IL-6 is another cytokine released by macrophages at muscle injury sites. It is normally a pro-
inflammatory cytokine but has been shown to be anti-inflammatory in muscle tissue and have 
inhibitory effects on pro-inflammatory cytokines, such as TNF-ɑ and IL-1 (Pedersen & Febbraio; 
Steensberg and Schjerling). IL-6 is secreted by infiltrating macrophages and neutrophiles, and 
myofibers themselves. It has become well-established that IL-6 is also produced by skeletal 
muscle, thus referred to as a “myokine” in that context (Pedersen & Febbraio; Snijders et al). 
Within target cells, including SCs, IL-6 reception induces the dimerization of tyrosine kinase 
receptor gp130. Downstream of this includes the activation of transcription 3 (STAT3), which 
activates the transcription of various genes. Additionally, gp130 dimerization activates 
phosphatidylinositol-3 kinase and members of the mitogen-activated protein kinase (MAPK) 
group. A mammalian MAPK, p38, positively regulates myoblast differentiation by upregulating 
MRF4 (Raingeaud, Gupta and Rogers).  
IL-6 receptor expression is upregulated in SCs following muscular damage, but seems to 
have a pleiotropic effect on SKM related to temporal release and local concentration. High 
concentrations of IL-6 may inhibit myogenic progression through disruption of intracellular GF 
signaling, resulting in compensatory IGF-1 production. IL-6 has paradoxically been observed in 
persistent inflammation and mediation of muscle wasting (Howard et al; Snijders et al). This 
current knowledge involving IL-6 mediation of muscle regeneration suggests a potent role in SC 
regulation, however there is evidence of divergent roles of IL-6 for both mediating SC activity 
and impairing muscle regeneration. Ongoing research into the concentration-dependent actions 
of IL-6 in inflammatory signaling will likely elucidate the mechanisms behind opposing roles of 
myogenic facilitation and persistent inflammation and muscle atrophy. While the role in 
persistent inflammation and promotion of muscle atrophy is not yet fully understood, the effects 
of IL-6 signaling in low concentrations of modulating SC proliferation and enhancing myoblast 
differentiation have been experimentally observed and replicated (Howard et al; (Serrano, 





VII . Current Research & Clinical Prospects 
VIII. Conclusion 
As the established major actors in skeletal muscle regeneration, satellite cells are an irrefutably 
important subject of research. The interactions satellite cells with their microenvironment, 
immune cells, and signaling molecules modulate their activation and the later regenerative 
activities of their myogenic progeny. Understanding the activation and regulation of satellite cells 
not only aids the understanding of normal physiology but provides valuable insight for the 
improvement of current clinical approaches. Ongoing research into the numerous regulatory 
dynamics of muscle regeneration will better the scientific understanding of regenerative 
dysfunctions and provide basis for the development of future treatments.  
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